PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 4W2O

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-*	-1	AASGGTFSINTLG	BBBLBBAAABBBB
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	55.6	H2	9	H2-9-1	19	RISSGGITR	BBBAALBBB
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	0.0	H3	12	H3-12-*	-1	MYRNWGGGLDVY	BBBBBEALLBBB
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	87.5	H4	8	H4-8-*	-1	RDNGKNTV	BBBLALBB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-*	-1	AASGGTFSINTLG	BBBLBBAAABBBB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	55.6	H2	9	H2-9-1	20	RISSGGITR	BBBAALBBB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	0.0	H3	12	H3-12-*	-1	MYRNWGGGLDVY	BBBBBEALLBBB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	87.5	H4	8	H4-8-*	-1	RDNGKNTV	BBBLALBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-*	-1	AASGGTFSINTLG	BBBLBBAAABBBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	55.6	H2	9	H2-9-1	20	RISSGGITR	BBBAALBBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	0.0	H3	12	H3-12-*	-1	MYRNWGGGLDVY	BBBBBEALLBBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	87.5	H4	8	H4-8-*	-1	RDNGKNTV	BBBLALBB
G	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-*	-1	AASGGTFSINTLG	BBBLBBAAABBBB
G	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	55.6	H2	9	H2-9-1	19	RISSGGITR	BBBAALBBB
G	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	0.0	H3	12	H3-12-*	-1	MYRNWGGGLDVY	BBBBBEALLBBB
G	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	87.5	H4	8	H4-8-*	-1	RDNGKNTV	BBBLALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on July 15, 2024